Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.
about
Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-AnalysisKilling cancer with platycodin D through multiple mechanismsEmerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerTargeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer CellsPancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesThe Complex Role of STAT3 in Viral InfectionsUnraveling the Anticancer Effect of Curcumin and ResveratrolOptimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion CellsCapsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancerLow-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.Phytochemicals potently inhibit migration of metastatic breast cancer cellsAlteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.Embryonic Stem Cells Promoting Macrophage Survival and Function are Crucial for Teratoma DevelopmentTetramethoxychalcone, a chalcone derivative, suppresses proliferation, blocks cell cycle progression, and induces apoptosis of human ovarian cancer cells.Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.δ-tocotrienol induces human bladder cancer cell growth arrest, apoptosis and chemosensitization through inhibition of STAT3 pathway.Th22 cell accumulation is associated with colorectal cancer developmentSTAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3.Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues.Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell linesResveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In VivoEffect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.Prognostic Significance of Serine-Phosphorylated STAT3 Expression in pT1-T2 Oral Tongue Carcinoma.Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cells.CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3.Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway.Targeting cancer by binding iron: Dissecting cellular signaling pathwaysFXR induces SOCS3 and suppresses hepatocellular carcinoma.(E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targetsTumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC.High expression of WDR1 in primary glioblastoma is associated with poor prognosis.Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
P2860
Q26769034-2087FDD9-ED59-4EA9-8194-5DF9A1F5E412Q26773408-2D0855BB-1401-4591-BE18-A33D3F7E4B8AQ26778509-9BAADE27-155F-48D0-89B6-303BC4E15B76Q26798203-3A786B5F-4730-4CCB-87A0-9BC9EC4AEDD8Q26799714-45FCC1FC-8DAE-4A7D-B491-2E144BACCA40Q26801053-7A9052D6-7032-4830-BB67-EB7A078800B7Q28073155-AA0B8B13-7010-4366-87EF-4681E6C8A8B7Q30276422-D3675623-B2A9-45E4-9632-7A027B7CB025Q30303147-11DCCC49-5FDD-4D47-A02E-4BFB7D844A8EQ30370132-5C8EF3D4-DB6D-4E0C-BC33-976F66EC67FCQ33566628-D6F46A95-5F6A-4B11-8595-4382FC8AFBAAQ33634260-AE1C8DF3-42BC-4BD5-AD6C-AC2FDF78BFCFQ33670486-EDF8C5D4-D9DA-464D-AE9C-9B200F6B1172Q33767626-8A6A9381-F041-48B2-BD70-D17A81AA49C3Q33810248-412DD85B-DF19-4EF9-ADE8-F5D8D50B042CQ33838824-2A80F268-6001-4E45-AE26-00E798100C2EQ33847075-630338B9-597B-4BF2-867B-518D47240364Q34121811-475DCA1F-F3F8-42F5-99E9-5DF7F290ACCAQ34742904-5084BD8E-C282-4615-84E2-947B2C7CBA39Q35301664-5D007C98-4822-48C3-BB1C-025D152E1D67Q35375460-82FC0224-5087-4A06-AABA-E45BC89716BDQ35405293-CEDD8065-AB71-49BF-BD0C-4C25F13103E1Q35579670-72DDD982-24F3-4837-9949-74F11F72FBFCQ35606710-B72D7279-82F3-4372-BE5E-D4841602DE51Q35745008-F92F1767-D63A-4847-AA17-F3783F92DB4BQ35928999-974E540B-8084-4CF8-8F68-235FE97CC729Q35934532-87394760-A550-4EE0-9FC6-81B593F77D79Q35956464-88D1EEE9-B95C-4AED-B19A-673CD2348385Q35964637-4EF259C2-7F53-4E3E-A2AC-C5EBF57290CAQ36006777-92C18862-70F6-4032-B869-C8E41275E30FQ36081452-58030F60-09A9-4133-A073-3BCD8FF56621Q36082118-5E6EB7B4-EACA-4C36-9ED4-817F0F2ED7ECQ36176779-66E9C575-C669-41DD-A147-E190F9726266Q36326247-8A7C865B-D70F-4B08-8824-D2F784D510F9Q36544161-647EAD4B-9492-496C-B481-5297190664F3Q36561629-FED24917-B5DD-41B1-8A5A-A8141AC3CE72Q36682108-B7FA104B-5A26-4AE4-B5D9-6D4898824DBFQ36685448-DFC0F0F4-54AA-42AA-98CE-93FD446984D1Q36841395-B6700A8E-4446-4319-997F-0D4F8BA8B7D8Q36907427-272AC110-3AC1-4F47-B6FE-AF251B636F87
P2860
Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting the STAT3 signaling ...... thetic and natural inhibitors.
@ast
Targeting the STAT3 signaling ...... thetic and natural inhibitors.
@en
type
label
Targeting the STAT3 signaling ...... thetic and natural inhibitors.
@ast
Targeting the STAT3 signaling ...... thetic and natural inhibitors.
@en
prefLabel
Targeting the STAT3 signaling ...... thetic and natural inhibitors.
@ast
Targeting the STAT3 signaling ...... thetic and natural inhibitors.
@en
P2093
P1476
Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors
@en
P2093
Alan Prem Kumar
Anupam Bishayee
Benny K H Tan
Jingwen Zhang
Kodappully Sivaraman Siveen
Rohit Surana
Sakshi Sikka
Xiaoyun Dai
P304
P356
10.1016/J.BBCAN.2013.12.005
P407
P50
P577
2014-01-02T00:00:00Z